Diabetes Treatment : New Diabetic Treatment
Diabetes Treatment :
I found some crucial and helpful information every diabetic should know. A newly developed drug available in Europe is waiting for FDA approval for American patients. Europe is now using this promising new breakthrough drug that has exceeded its predecessors. Liraglutide is a human GLP-1 analog with high homology (97%) to native hormone; its branded name in Europe is Victoza. GLP-1 analogs has promised diabetes patients long-term efficacy, low risk of hypoglycemia, cardiovascular protection, weight loss, long-term safety and tolerability.Here are some scary statistics I found…1. In the United States and more recently worldwide, type 2 Diabetes has reached epidemic proportions.2. Approximately 246 million people has been diagnose with diabetes worldwide, and that number is expected to increase to 380 million by 2025.3. Ninety to ninety five percent of all diabetes cases is accounted for by type 2 Diabetes and ninety percent of those cases are either overweight or obese.Free Diabetic InformationStudies conducted on the new Novo Nordisk drug liraglutide proved it effectively controls blood sugar, reduces high cholesterol and other metabolic risk factors for heart disease. The once-daily diabetes drug is administered as an isotonic solution through subcutaneous injection and was well tolerated, significantly improved metabolic control, and reduced body weight with low rates of hypoglycemia. The most common side effect experienced by patients was transient nausea.The FDA approval date for liraglutide is unknown at this time.Free Diabetic Information
Tags:Diabetic Treatments,Diabetic Information,Diabetic Research
Tags: 
Loading ...